Roche subsidiary Genentech has provided an update in its multiple sclerosis program, revealing a partial trial stoppage for the oral BTK inhibitor fenebrutinib. 5 December 2023
Boston-based biopharma Karuna Therapeutics has announced the US Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for KarXT (xanome 30 November 2023
In 1984, Congress passed and the President signed into law the Drug Price Competition and Patent Term Restoration Act, better known as the Hatch-Waxman Act. 21 November 2023
Aurobindo Pharma subsidiary Acrotech Biopharma has been urged to work with the US Food and Drug Administration (FDA) to swiftly advance a confirmatory trial of 20 November 2023
Leading checkpoint blocker Keytruda (pembrolizumab) has picked up a new American approval, in combination with chemotherapy, for the first-line treatment of cer 17 November 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.